102 related articles for article (PubMed ID: 20638192)
1. Daily megavoltage computed tomography in lung cancer radiotherapy: correlation between volumetric changes and local outcome.
Bral S; De Ridder M; Duchateau M; Gevaert T; Engels B; Schallier D; Storme G
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1338-42. PubMed ID: 20638192
[TBL] [Abstract][Full Text] [Related]
2. Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect?
Siker ML; Tomé WA; Mehta MP
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):135-41. PubMed ID: 16839704
[TBL] [Abstract][Full Text] [Related]
3. Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC.
Bral S; Duchateau M; De Ridder M; Everaert H; Tournel K; Schallier D; Verellen D; Storme G
Radiother Oncol; 2009 Jun; 91(3):438-42. PubMed ID: 19368985
[TBL] [Abstract][Full Text] [Related]
4. Shrinkage of locally advanced non-small-cell lung cancers in response to induction chemotherapy: implications for radiotherapy treatment planning.
Jenkins P; Milliner R; Latimer P
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):993-1000. PubMed ID: 17869016
[TBL] [Abstract][Full Text] [Related]
5. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
Liao ZX; Komaki RR; Thames HD; Liu HH; Tucker SL; Mohan R; Martel MK; Wei X; Yang K; Kim ES; Blumenschein G; Hong WK; Cox JD
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):775-81. PubMed ID: 19515503
[TBL] [Abstract][Full Text] [Related]
6. Volume or position changes of primary lung tumor during (chemo-)radiotherapy cannot be used as a surrogate for mediastinal lymph node changes: the case for optimal mediastinal lymph node imaging during radiotherapy.
van Elmpt W; Ollers M; van Herwijnen H; den Holder L; Vercoulen L; Wouters M; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):89-95. PubMed ID: 20421149
[TBL] [Abstract][Full Text] [Related]
7. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.
Guckenberger M; Wilbert J; Richter A; Baier K; Flentje M
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):901-8. PubMed ID: 20708850
[TBL] [Abstract][Full Text] [Related]
8. Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer.
Fox J; Ford E; Redmond K; Zhou J; Wong J; Song DY
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):341-8. PubMed ID: 19038504
[TBL] [Abstract][Full Text] [Related]
9. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract][Full Text] [Related]
10. Sequential chemoradiotherapy with accelerated hypofractionated radiotherapy compared to concurrent chemoradiotherapy with standard radiotherapy for locally advanced non-small cell lung cancer.
Zhu ZF; Ma HL; Fan M; Bao Y; Zhuang TT; Chen M; Jiang GL; Fu XL
Technol Cancer Res Treat; 2014 Jun; 13(3):269-75. PubMed ID: 24066952
[TBL] [Abstract][Full Text] [Related]
11. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
[TBL] [Abstract][Full Text] [Related]
12. Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy.
Song CH; Pyo H; Moon SH; Kim TH; Kim DW; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):651-8. PubMed ID: 20207499
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of epidermal growth factor receptor tyrosine kinase inhibitors concurrent with individualized radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer.
Wang J; Xia TY; Wang YJ; Li HQ; Li P; Wang JD; Chang DS; Liu LY; Di YP; Wang X; Wu WZ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e59-65. PubMed ID: 21345607
[TBL] [Abstract][Full Text] [Related]
14. Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.
McAleer MF; Moughan J; Byhardt RW; Cox JD; Sause WT; Komaki R
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):802-8. PubMed ID: 19540055
[TBL] [Abstract][Full Text] [Related]
15. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
[TBL] [Abstract][Full Text] [Related]
16. Tumor regression and positional changes in non-small cell lung cancer during radical radiotherapy.
Lim G; Bezjak A; Higgins J; Moseley D; Hope AJ; Sun A; Cho JB; Brade AM; Ma C; Bissonnette JP
J Thorac Oncol; 2011 Mar; 6(3):531-6. PubMed ID: 21258244
[TBL] [Abstract][Full Text] [Related]
17. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
Bonner JA; McGinnis WL; Stella PJ; Marschke RF; Sloan JA; Shaw EG; Mailliard JA; Creagan ET; Ahuja RK; Johnson PA
Cancer; 1998 Mar; 82(6):1037-48. PubMed ID: 9506347
[TBL] [Abstract][Full Text] [Related]
18. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment.
Kupelian PA; Ramsey C; Meeks SL; Willoughby TR; Forbes A; Wagner TH; Langen KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1024-8. PubMed ID: 16005575
[TBL] [Abstract][Full Text] [Related]
19. Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy.
Bral S; Duchateau M; Versmessen H; Engels B; Tournel K; Vinh-Hung V; De Ridder M; Schallier D; Storme G
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1352-9. PubMed ID: 20056350
[TBL] [Abstract][Full Text] [Related]
20. [Advances in research on biological target volume and conformal intensity-modulated radiotherapy].
Yu JM; Chen SQ
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):801-3. PubMed ID: 17415998
[No Abstract] [Full Text] [Related]
[Next] [New Search]
